Whats gone wrong ADO ?- And HOW to fix things fast, page-175

Totally agree, a quick look at Quidel is the US should give us much optimism about the next 12 months. Currently, they had to pre-announce revenue as they blew revenue estimates, Market Cap of $5.8bn with $1bn of revenue. Yes, share price is significantly off the historic inflated highs due to forward projections to 2025 post covid, it is still at $140 (probably a little undervalued). Go back in history and in 2017 Qudiel did $277m in Revenue and roughly broke even and had a market cap of roughly US$1.675bn.

ADO could soon have TGA approval amongst others and could easily see sales for 30m tests at say US$10 a test, gives $300m revenue line in 12 months. If valued the same as Quidel back in 2017 then 5x current share price at AUD$1.25. Add battery tech and who knows $2.50.

So the future is very bright if we learn from the past and make some changes quickly, the AGM as you say is the perfect opportunity for change to occur and then progress can be accelerated.